Citation Tools
PDFRegular and Young Investigator Award Abstracts
Clinical Trial In Progress
661 Dipeptidyl peptidase-9 (DPP9) overexpression is a potential response-predictive biomarker of BXCL701 and pembrolizumab combination treatment in mCRPC patients with SCNC phenotype
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- 661 Dipeptidyl peptidase-9 (DPP9) overexpression is a potential response-predictive biomarker of BXCL701 and pembrolizumab combination treatment in mCRPC patients with SCNC phenotype